Therapeutic Group: SARS-CoV-2 main protease (Mpro: also referred to as 3CLpro or nsp5 protease) inhibitor, and Ritonavir, an HIV-1 protease inhibitor and CYP3A inhibitor. Presentation Nirmatrelvir tablet: Each film-coated Nirmatrelvir tablet contains Nirmatrelvir INN 150 mg. Ritonavir tablet: Each film-coated Ritonavir tablet contains Ritonavir USP 100 mg Description Emergency Use Authorization (EUA) for the treatment […]